ANIP vs ROL · rev $503.5M vs P/E 41, rev $1.99B
ANI Pharmaceuticals Inc (ANIP) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ANIP currently screens at market cap $1.41B. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ANIP and ROL stock pages for the full models.
Not investment advice.